197 related articles for article (PubMed ID: 32930510)
1. Male breast cancer: A closer look at patient and tumor characteristics and factors associated with survival.
Zhao J; Wang B; Zhao J; Mao Y; Liu J; Yang Y
Thorac Cancer; 2020 Nov; 11(11):3107-3116. PubMed ID: 32930510
[TBL] [Abstract][Full Text] [Related]
2. A Prognostic Analysis of Male Breast Cancer (MBC) Compared with Post-Menopausal Female Breast Cancer (FBC).
Yu XF; Yang HJ; Yu Y; Zou DH; Miao LL
PLoS One; 2015; 10(8):e0136670. PubMed ID: 26313461
[TBL] [Abstract][Full Text] [Related]
3. Hormone Receptor-Positive Breast Cancer Has a Worse Prognosis in Male Than in Female Patients.
Li X; Yang J; Krishnamurti U; Huo L; Ward KC; O'Regan R; Peng L
Clin Breast Cancer; 2017 Aug; 17(5):356-366. PubMed ID: 28576631
[TBL] [Abstract][Full Text] [Related]
4. Poor prognosis of male triple-positive breast Cancer patients: a propensity score matched SEER analysis and molecular portraits.
Wang B; Wang H; Zhao A; Zhang M; Yang J
BMC Cancer; 2021 May; 21(1):523. PubMed ID: 33964913
[TBL] [Abstract][Full Text] [Related]
5. Overall Survival of Men and Women With Breast Cancer According to Tumor Subtype: A Population-based Study.
Leone J; Zwenger AO; Leone BA; Vallejo CT; Leone JP
Am J Clin Oncol; 2019 Feb; 42(2):215-220. PubMed ID: 30499840
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic characteristics and survival of male breast cancer.
Liu D; Xie G; Chen M
Int J Clin Oncol; 2014 Apr; 19(2):280-7. PubMed ID: 23640121
[TBL] [Abstract][Full Text] [Related]
7. Survival benefit of tamoxifen and aromatase inhibitor in male and female breast cancer.
Eggemann H; Altmann U; Costa SD; Ignatov A
J Cancer Res Clin Oncol; 2018 Feb; 144(2):337-341. PubMed ID: 29098396
[TBL] [Abstract][Full Text] [Related]
8. Male breast cancer: Looking for better prognostic subgroups.
Abreu MH; Afonso N; Abreu PH; Menezes F; Lopes P; Henrique R; Pereira D; Lopes C
Breast; 2016 Apr; 26():18-24. PubMed ID: 27017238
[TBL] [Abstract][Full Text] [Related]
9. Male breast cancer in the veterans affairs population: a comparative analysis.
Nahleh ZA; Srikantiah R; Safa M; Jazieh AR; Muhleman A; Komrokji R
Cancer; 2007 Apr; 109(8):1471-7. PubMed ID: 17342768
[TBL] [Abstract][Full Text] [Related]
10. Comparison between male and female breast cancer survival using propensity score matching analysis.
Scomersi S; Giudici F; Cacciatore G; Losurdo P; Fracon S; Cortinovis S; Ceccherini R; Zanconati F; Tonutti M; Bortul M
Sci Rep; 2021 Jun; 11(1):11639. PubMed ID: 34079019
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic characteristics and prognosis for male breast cancer compared to female breast cancer.
Yao N; Shi W; Liu T; Siyin ST; Wang W; Duan N; Xu G; Qu J
Sci Rep; 2022 Jan; 12(1):220. PubMed ID: 34997151
[TBL] [Abstract][Full Text] [Related]
12. Poorer breast cancer survival outcomes in males than females might be attributable to tumor subtype.
Wu Q; Li J; Zhu S; Wu J; Li X; Liu Q; Wei W; Sun S
Oncotarget; 2016 Dec; 7(52):87532-87542. PubMed ID: 27655704
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Korean Male Breast Cancer Using an Online Nationwide Breast-Cancer Database: Matched-Pair Analysis of Patients With Female Breast Cancer.
Choi MY; Lee SK; Lee JE; Park HS; Lim ST; Jung Y; Ko BK; Nam SJ;
Medicine (Baltimore); 2016 Apr; 95(16):e3299. PubMed ID: 27100414
[TBL] [Abstract][Full Text] [Related]
14. Molecular subtyping of male breast cancer using alternative definitions and its prognostic impact.
Nilsson C; Johansson I; Ahlin C; Thorstenson S; Amini RM; Holmqvist M; Bergkvist L; Hedenfalk I; Fjällskog ML
Acta Oncol; 2013 Jan; 52(1):102-9. PubMed ID: 22928693
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarker.
Johansson I; Nilsson C; Berglund P; Lauss M; Ringnér M; Olsson H; Luts L; Sim E; Thorstensson S; Fjällskog ML; Hedenfalk I
Breast Cancer Res; 2012 Feb; 14(1):R31. PubMed ID: 22333393
[TBL] [Abstract][Full Text] [Related]
16. Dachshund 1 is Differentially Expressed Between Male and Female Breast Cancer: A Matched Case-Control Study of Clinical Characteristics and Prognosis.
Cui Q; Kong D; Li Z; Ahiable P; Wang K; Wu K; Wu G
Clin Breast Cancer; 2018 Oct; 18(5):e875-e882. PubMed ID: 29478945
[TBL] [Abstract][Full Text] [Related]
17. Men and women show similar survival outcome in stage IV breast cancer.
Wu SG; Zhang WW; Liao XL; Sun JY; Li FY; Su JJ; He ZY
Breast; 2017 Aug; 34():115-121. PubMed ID: 28577471
[TBL] [Abstract][Full Text] [Related]
18. [Analysis on the clinical and prognostic features of 71 male patients with breast cancer].
Liu DY; Xie GR; Chen M
Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Feb; 34(2):187-90. PubMed ID: 23751479
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological features of male patients with breast cancer based on a nationwide registry database in Japan.
Shimomura A; Nagahashi M; Kumamaru H; Aogi K; Asaga S; Hayashi N; Iijima K; Kadoya T; Kojima Y; Kubo M; Miyashita M; Miyata H; Niikura N; Ogo E; Tamura K; Tanakura K; Yoshida M; Yamamoto Y; Imoto S; Jinno H
Breast Cancer; 2022 Nov; 29(6):985-992. PubMed ID: 35733033
[TBL] [Abstract][Full Text] [Related]
20. Favorable Long-Term Outcome in Male Breast Cancer.
Özkurt E; Tükenmez M; Yılmaz R; Cabioğlu N; Müslümanoğlu M; Dinççağ AS; İğci A; Özmen V
Eur J Breast Health; 2018 Jul; 14(3):180-185. PubMed ID: 30123885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]